等待开盘 11-19 09:30:00 美东时间
+1.020
+1.49%
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 10:22
Wells Fargo analyst Elyse Greenspan maintains Voya Financial (NYSE:VOYA) with a Equal-Weight and lowers the price target from $83 to $80.
11-08 02:40
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Voya Financial业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **整体业绩表现:** - 调整后运营每股收益达到2.45美元,同比增长近30% - 第三季度超额资本生成超过2亿美元,年初至今累计约6亿美元 - 股东权益回报率提升至18% - 第三季度向股东返还约1.5亿美元资本,包括1亿美元股票回购 **各业务板块收益表现:** - 退休业务:调整后运营收益2.61亿美元,同比增长24%,过去十二个月增长20% - 投资管理业务:调整后运营收益6200万美元,同比增长13%,过去十二个月增长15% - 员工福利业务:调整
11-06 12:55
Earnings Call Insights: Voya Financial (VOYA) Q3 2025 Management View Heather Lavallee, President, CEO & Director, opened by highlighting "strong third quarter results that reflect meaningful progress...
11-06 03:32
Voya Financial (NYSE:VOYA) reported quarterly earnings of $2.45 per share which beat the analyst consensus estimate of $2.22 by 10.26 percent. This is a 15.57 percent increase over earnings of $2.12 per share from the
11-05 05:28
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Voya Financial (NYSE:VOYA) is preparing to release its quarterly earnings on Tu...
11-04 01:02
Voya Financial, Inc. (NYSE: VOYA) announced today that its board of directors has declared a 4.4% increase in the company's common stock dividend to $0.47 per share from $0.45 per share for the fourth quarter of 2025.
10-31 04:24